Show simple item record

dc.contributor.authorMoore, Jennifer
dc.date.available2016-01-11T00:50:58Z
dc.date.copyright2011
dc.identifier.citationJennifer Moore "Is New Zealand’s Regulation of Nanomedicines Adequate?" (2011) 19 Journal of Law and Medicine 112-127.en_NZ
dc.identifier.urihttp://hdl.handle.net/10523/6153
dc.description.abstractThis article investigates the adequacy of New Zealand's regulation of medical products produced by nanotechnology and containing nanomaterials. There is concern that the novel and unique properties of some nanoscale chemical substances will bring unforeseen human and environmental health and safety risks. Given the possible market for nanomedicines and their potential risks, it is important to have adequate regulation of nanomedicines in order to prevent adverse public health ramifications. This article argues that nanoparticles, invisible to the human eye, are illuminating and exacerbating, legislative imperfections in the Medicines Act 1981 (NZ). This Act does not include a pre-market approval process for medical devices, nor does it include provisions for combination products. This approach is inconsistent with international norms. The article proposes amendment of the Medicines Act 1981 (NZ) to address these weaknesses and the novel challenges posed by nanomedicines.en_NZ
dc.language.isoenen_NZ
dc.publisherThomson Reutersen_NZ
dc.relation.ispartofJournal of Law and Medicineen_NZ
dc.subjectnanomedicineen_NZ
dc.subjectregulation of nanotechnologyen_NZ
dc.subjectmedicines legislationen_NZ
dc.subjectmedical devicesen_NZ
dc.subjectpharmaceuticalsen_NZ
dc.subjectrisken_NZ
dc.titleIs New Zealand’s Regulation of Nanomedicines Adequate?en_NZ
dc.typeJournal Articleen_NZ
dc.date.updated2016-01-10T18:37:14Z
otago.schoolFaculty of Lawen_NZ
otago.relation.volume19en_NZ
otago.bitstream.endpage127en_NZ
otago.bitstream.startpage112en_NZ
otago.openaccessAbstract Only
dc.rights.statementPlease note that this article is being provided for research purposes and is not to be reproduced in any way. If you refer to the article, please ensure you acknowledge both the publication and the publisher appropriately. The citation for the journal is available in the footline of each page. Should you wish to reproduce this article, either in part of in its entirety, in any medium, please ensure you seek permission from our Permissions Officer. Email: LTA.permissions@thomsonreuters.comen_NZ
dc.description.refereedPeer Revieweden_NZ
 Find in your library

Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item is not available in full-text via OUR Archive.

If you are the author of this item, please contact us if you wish to discuss making the full text publicly available.

This item appears in the following Collection(s)

Show simple item record